Thompson Siegel & Walmsley LLC Novartis Ag Transaction History

Thompson Siegel & Walmsley LLC

$6.71 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$80.03 - $92.81 $56,021 - $64,967	-700 Reduced 75.35%	229 $21,000
Q4 2022 Feb 10, 2023	BUY	$75.55 - $92.52 $70,185 - $85,951	929 New	929 $84,000
Q2 2022 Jul 22, 2022	SELL	$80.52 - $93.75 $36,797 - $42,843	-457 Reduced 32.97%	929 $79,000
Q1 2022 Apr 26, 2022	SELL	$80.11 - $90.62 $44,941 - $50,837	-561 Reduced 28.81%	1,386 $122,000
Q4 2021 Feb 09, 2022	SELL	$79.7 - $88.13 $7,412 - $8,196	-93 Reduced 4.56%	1,947 $170,000
Q3 2021 Nov 05, 2021	SELL	$81.78 - $95.14 $31,485 - $36,628	-385 Reduced 15.88%	2,040 $167,000
Q2 2021 Aug 09, 2021	SELL	$85.24 - $94.15 $21,310 - $23,537	-250 Reduced 9.35%	2,425 $221,000
Q4 2020 Feb 08, 2021	SELL	$78.07 - $94.43 $3,903 - $4,721	-50 Reduced 1.83%	2,675 $253,000
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $2,628 - $2,912	-32 Reduced 1.16%	2,725 $237,000
Q2 2020 Aug 11, 2020	SELL	$80.93 - $91.1 $15,619 - $17,582	-193 Reduced 6.54%	2,757 $241,000
Q1 2020 May 12, 2020	SELL	$70.67 - $99.01 $20,140 - $28,217	-285 Reduced 8.81%	2,950 $243,000
Q4 2019 Feb 07, 2020	SELL	$84.35 - $95.37 $4,217 - $4,768	-50 Reduced 1.52%	3,235 $306,000
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $9,409 - $10,368	-110 Reduced 3.24%	3,285 $285,000
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $5,655 - $6,960	-75 Reduced 2.16%	3,395 $310,000
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $37,660 - $43,075	-500 Reduced 12.59%	3,470 $334,000
Q3 2018 Nov 08, 2018	SELL	$66.94 - $77.43 $6,694 - $7,743	-100 Reduced 2.46%	3,970 $342,000
Q2 2018 Aug 09, 2018	SELL	$64.91 - $73.36 $78,865 - $89,132	-1,215 Reduced 22.99%	4,070 $307,000
Q1 2018 May 08, 2018	SELL	$70.39 - $84.15 $49,273 - $58,905	-700 Reduced 11.7%	5,285 $427,000
Q4 2017 Feb 09, 2018	BUY	$72.33 - $77.64 $37,611 - $40,372	520 Added 9.52%	5,985 $503,000
Q2 2017 Aug 09, 2017	BUY	N/A	5,465	5,465 $456,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.

Account